APA (7th ed.) Citation

G, G., S, B., L, A., N, F., A, R., T, Z., . . . C, G. (2026). Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis. Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.70307

Chicago Style (17th ed.) Citation

G, Geidel, et al. "Role of Comorbidities and Medication on Immunotherapy Efficacy in CSCC: A DeCOG Multicentre Analysis." Journal of the European Academy of Dermatology and Venereology : JEADV 2026. https://doi.org/10.1111/jdv.70307.

MLA (9th ed.) Citation

G, Geidel, et al. "Role of Comorbidities and Medication on Immunotherapy Efficacy in CSCC: A DeCOG Multicentre Analysis." Journal of the European Academy of Dermatology and Venereology : JEADV, 2026, https://doi.org/10.1111/jdv.70307.